Financial Data and Key Metrics Changes - For Q4 2024, total revenues reached 50.1million,representinga22179.5 million, an 8% increase from 165.8millionin2023,withsignificantgrowthoccurringinthesecondhalfoftheyear[20][21]−GrossmarginforQ4was7210 million and spent about 18 million on CapEx related to the DFI ecosystem [26] - The accounts receivable balance was elevated due to timing and billing, but management expressed confidence in collections [60][62] Q&A Session Summary Question: Can you provide more details on the eProbe pipeline? - The eProbe sales will include both repeat sales to existing customers and new sales to new customers, with a focus on advanced logic and DRAM applications [35][36] Question: What is the status of the backlog? - The backlog decreased from 239 million in Q3 to $221 million, attributed to the nature of the new sales model [34][39] Question: How is customer adoption of model ops impacting growth? - Customer receptivity to model ops has been high, with ongoing pilots expected to contribute to business growth in 2025 [52][53] Question: What is the impact of elevated accounts receivable on cash flow? - The elevated accounts receivable is a matter of timing and billing, with management confident in the progress of collections [60][62] Question: How are management changes at key customers affecting business? - Management changes at customers have not significantly impacted business, as the company has diversified its customer base [72][76] Question: Is there increased activity in advanced packaging due to market conditions? - The company is seeing increased activity in advanced packaging, particularly from leading-edge customers who are relying more on OSAT partners [80][82] Question: Are there opportunities in HBM DRAM with Exensio? - The company is starting to penetrate HBM DRAM accounts, particularly through the eProbe, which has reintroduced the company to this market segment [87][89]